Granules India informs about transcript of earnings call

Granules India Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 532482 | NSE: GRANULES

31 Jan 2023 Evaluate

Pursuant to regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Granules India has informed that the transcript of the earnings conference call of the Company held on January 24, 2023 for the third quarter and nine-months ended on December 31, 2022 has been enclosed and uploaded on the website of the Company at the below-mentioned link: https://granulesindia.com/investors/investor-resources/earnings-call-transcripts/.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1853.15
Dr. Reddys Labs.	1190.20
Cipla	1374.60
Lupin	2087.65
Zydus Lifesciences	1154.80
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.